110 related articles for article (PubMed ID: 7675780)
1. Intestinal pseudo-obstruction and ischemia secondary to both beta 2-microglobulin and serum A amyloid deposition.
Borczuk A; Mannion C; Dickson D; Alt E
Mod Pathol; 1995 Jun; 8(5):577-82. PubMed ID: 7675780
[TBL] [Abstract][Full Text] [Related]
2. Chronic intestinal pseudo-obstruction due to dialysis-related amyloid deposition in the propria muscularis in a hemodialysis patient.
Kanai H; Kashiwagi M; Hirakata H; Nagashima A; Tada S; Yao T; Nakamoto M; Nakamura S; Fujishima M
Clin Nephrol; 2000 May; 53(5):394-9. PubMed ID: 11305814
[TBL] [Abstract][Full Text] [Related]
3. Generalized beta 2-microglobulin deposition. A preamyloidosis disorder?
Terreros DA; Knight JA; Peric-Golia L; Cheung AK
Arch Pathol Lab Med; 1989 Jan; 113(1):31-5. PubMed ID: 2491942
[TBL] [Abstract][Full Text] [Related]
4. Intestinal pseudo-obstruction due to dialysis amyloidosis.
Shinoda T; Komatsu M; Aizawa T; Shirota T; Yamada T; Ehara T; Mizukami E
Clin Nephrol; 1989 Dec; 32(6):284-9. PubMed ID: 2612073
[TBL] [Abstract][Full Text] [Related]
5. Electron microscopic characteristics of beta2-microglobulin amyloid deposits in long-term haemodialysis.
Bély M; Kapp P; Szabó TS; Lakatos T; Apáthy A
Ultrastruct Pathol; 2005; 29(6):483-91. PubMed ID: 16316949
[TBL] [Abstract][Full Text] [Related]
6. Nodular macroglossia with combined light chain and beta-2 microglobulin deposition in a long-term dialysis patient.
Bandini S; Bergesio F; Conti P; Mancini G; Cerretini C; Cirami C; Rosati A; Caselli GM; Arbustini E; Merlini G; Ficarra G; Salvadori M
J Nephrol; 2001; 14(2):128-31. PubMed ID: 11411015
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous and lingual papules as a sign of beta 2 microglobulin-derived amyloidosis in a long-term hemodialysis patient.
Uenotsuchi T; Imafuku S; Nagata M; Kiryu H; Morita K; Koga T; Furue M
Eur J Dermatol; 2003; 13(4):393-5. PubMed ID: 12948922
[TBL] [Abstract][Full Text] [Related]
8. [Mixed type amyloidomas, beta2 microglobulin and AL lambda, in a long term hemodialysis patient].
Menet E; Petit ML; Bridoux F; Touchard G; Duport G; Levillain P; Babin P
Nephrologie; 2001; 22(3):115-8. PubMed ID: 11436666
[TBL] [Abstract][Full Text] [Related]
9. [Inflammatory cell infiltration around beta 2-microglobulin amyloid deposition: histologic comparison of beta 2-microglobulin amyloidosis with AA or AL amyloidosis].
Kawai R; Oohashi K; Hara M; Ogura Y; Honda K; Nihei H; Mimura N
Nihon Jinzo Gakkai Shi; 1992 Jun; 34(6):683-91. PubMed ID: 1479708
[TBL] [Abstract][Full Text] [Related]
10. [Beta 2-microglobulin amyloidosis presenting as intestinal perforation in a haemodialysis patient].
Farah-Klibi F; Ferchichi L; Jarboui S; Ben Slama S; Zaouche A; Ben Jilani S; Zermani R
Rev Med Interne; 2007 Apr; 28(4):269-71. PubMed ID: 17349721
[TBL] [Abstract][Full Text] [Related]
11. Right colonic involvement is associated with severe forms of ischemic colitis and occurs frequently in patients with chronic renal failure requiring hemodialysis.
Flobert C; Cellier C; Berger A; Ngo A; Cuillerier E; Landi B; Marteau P; Cugnenc PH; Barbier JP
Am J Gastroenterol; 2000 Jan; 95(1):195-8. PubMed ID: 10638582
[TBL] [Abstract][Full Text] [Related]
12. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.
Traut M; Haufe CC; Eismann U; Deppisch RM; Stein G; Wolf G
Blood Purif; 2007; 25(5-6):432-40. PubMed ID: 17957097
[TBL] [Abstract][Full Text] [Related]
13. Systemic distribution of beta 2-microglobulin-derived amyloidosis in patients who undergo long-term hemodialysis. Report of seven cases and review of the literature.
Gal R; Korzets A; Schwartz A; Rath-Wolfson L; Gafter U
Arch Pathol Lab Med; 1994 Jul; 118(7):718-21. PubMed ID: 8024407
[TBL] [Abstract][Full Text] [Related]
14. Intestinal pseudo-obstruction associated with amyloidosis.
Liapis K; Michelis FV; Delimpasi S; Karmiris T
Amyloid; 2011 Jun; 18(2):76-8. PubMed ID: 21247244
[TBL] [Abstract][Full Text] [Related]
15. [Systemic AA amyloidosis induced by benign neoplasms].
Bestard Matamoros O; Poveda Monje R; Ibernon Vilaró M; Carrera Plans M; Grinyó Boira JM
Nefrologia; 2008; 28(1):93-8. PubMed ID: 18336138
[TBL] [Abstract][Full Text] [Related]
16. Serum beta 2-microglobulin concentration in dialysis patients: importance of intrinsic renal function.
McCarthy JT; Williams AW; Johnson WJ
J Lab Clin Med; 1994 Apr; 123(4):495-505. PubMed ID: 8144998
[TBL] [Abstract][Full Text] [Related]
17. Current clinical aspects of dialysis-related amyloidosis in chronic dialysis patients.
Saito A; Gejyo F
Ther Apher Dial; 2006 Aug; 10(4):316-20. PubMed ID: 16911183
[TBL] [Abstract][Full Text] [Related]
18. Intestinal pseudo-obstruction in patients with amyloidosis: clinicopathologic differences between chemical types of amyloid protein.
Tada S; Iida M; Yao T; Kitamoto T; Yao T; Fujishima M
Gut; 1993 Oct; 34(10):1412-7. PubMed ID: 8244111
[TBL] [Abstract][Full Text] [Related]
19. [Mediators of amyloidogenesis and cytokines in dialysis-related amyloidosis].
Rysavá R; Merta M; Tesar V; Lachmanová J; Sulková S; Bláha J
Cas Lek Cesk; 2002 Apr; 141(8):244-7. PubMed ID: 12038073
[TBL] [Abstract][Full Text] [Related]
20. [Mechanism of beta(2)-microglobulin-related amyloid fibril formation in CKD].
Yamamoto S; Kazama JJ
Clin Calcium; 2007 May; 17(5):740-4. PubMed ID: 17471004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
